BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31360122)

  • 1. p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling.
    Zhang Y; Han CY; Duan FG; Fan XX; Yao XJ; Parks RJ; Tang YJ; Wang MF; Liu L; Tsang BK; Leung EL
    Cancer Cell Int; 2019; 19():188. PubMed ID: 31360122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M; Bai T; Tsang BK
    Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer
    Yan S; Zhang B; Feng J; Wu H; Duan N; Zhu Y; Zhao Y; Shen S; Zhang K; Wu W; Liu N
    Front Pharmacol; 2021; 12():764699. PubMed ID: 35126111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation.
    Kobayashi N; Abedini M; Sakuragi N; Tsang BK
    J Ovarian Res; 2013; 6():7. PubMed ID: 23351152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel Impedes EGFR-mutated PC9 Cell Growth
    Mohiuddin M; Kasahara K
    Cancer Genomics Proteomics; 2021; 18(5):645-659. PubMed ID: 34479917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
    Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
    Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines.
    Zhang L; Li J; Hu J; Li D; Wang X; Zhang R; Zhang H; Shi M; Chen H
    Lung Cancer; 2017 Jul; 109():109-116. PubMed ID: 28577939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling.
    Jin J; Yan X; Zhao Y; Zhang H; Zhuang K; Wen Y; He J; Gao J
    Oncol Lett; 2023 Jun; 25(6):224. PubMed ID: 37153044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
    Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
    J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway.
    Hua R; Pei Y; Gu H; Sun Y; He Y
    J BUON; 2020; 25(1):262-267. PubMed ID: 32277640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.
    Woo MG; Xue K; Liu J; McBride H; Tsang BK
    J Biol Chem; 2012 Feb; 287(6):3963-75. PubMed ID: 22117079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
    Wang LJ; Wang SG; Deng TX
    Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
    Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
    Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells
    Lin S; Qin HZ; Li ZY; Zhu H; Long L; Xu LB
    Front Pharmacol; 2022; 13():1049117. PubMed ID: 36523491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
    Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
    Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.